| Author |
Title |
JournalName |
Year D |
| Click on Column Headers to Re-Sort The Current List |
| Lamb RJ, Griffiths RR |
Self-injection of d,1-3,4-methylenedioxymethamphetamine (MDMA) in the ... |
Psychopharmacology (... |
1987 |
| Mansbach RS, Sannerud CA,... |
Intravenous self-administration of 4-methylaminorex in primates |
Drug Alcohol Depend |
1990 |
| Rush CR, Sullivan JT, Gri... |
Intravenous caffeine in stimulant drug abusers: subjective reports and... |
J Pharmacol Exp Ther |
1995 |
| Williamson S, Gossop M, P... |
Adverse effects of stimulant drugs in a community sample of drug users |
Drug Alcohol Depend |
1997 |
| Schuh KJ, Griffiths RR |
Caffeine reinforcement: the role of withdrawal |
Psychopharmacology (... |
1997 |
| Lerner AG |
Clonidine treatment for hallucinogen persisting perception disorder |
Am J Psychiatry |
1998 |
| Boys A, Marsden J, Griffi... |
Substance use among young people: the relationship between perceived f... |
Addiction |
1999 |
| Akram G, Galt M |
A profile of harm-reduction practices and co-use of illicit and licit ... |
Drugs: Education, Pr... |
1999 |
| Jones HE, Herning RI, Cad... |
Caffeine withdrawal increases cerebral blood flow velocity and alters ... |
Psychopharmacology B... |
2000 |
| Griffiths P, Vingoe L, et... |
Drug information systems, early warning, and new drug trends: can drug... |
Subst Use Misuse |
2000 |
| Winstock AR, Griffiths P,... |
Drugs and the dance music scene: a survey of current drug use patterns... |
Drug and Alcohol Dep... |
2000 |
| Griffiths RR, Richards WA... |
Psilocybin can occasion mystical-type experiences having substantial a... |
Psychopharmacology (... |
2006 |
| Nichols DE |
Commentary on: Psilocybin can occasion mystical-type experiences havin... |
Psychopharmacology (... |
2006 |
| Snyder SH |
Commentary on: Psilocybin can occasion mystical-type experiences havin... |
Psychopharmacology (... |
2006 |
| Schuster CR |
Commentary on: Psilocybin can occasion mystical-type experiences havin... |
Psychopharmacology (... |
2006 |
| Kleber HD |
Commentary on: Psilocybin can occasion mystical-type experiences havin... |
Psychopharmacology (... |
2006 |
| Carter LP, Richards BD, M... |
Relative Abuse Liability of GHB in Humans: A Comparison of Psychomotor... |
Neuropsychopharmacol... |
2006 |
| Griffiths RR, Richards WA... |
Mystical-type experiences occasioned by psilocybin mediate the attribu... |
J Psychopharm |
2008 |
| Johnson MW, Richards WA, ... |
Human hallucinogen research: guidelines for safety |
J Psychopharmacol. |
2008 |
| Reissig CJ, Strain EC, Gr... |
Caffeinated energy drinks-A growing problem |
Drug Alcohol Depend |
2008 |
| Griffiths Pl, Sedefov R, ... |
How globalization and market innovation challenge how we think about a... |
Addiction |
2010 |
| Johnson MW, Maclean KA, R... |
Human psychopharmacology and dose-effects of salvinorin A, a kappa opi... |
Drug Alcohol Depend |
2010 |
| MacLean KA, Johnson MW, G... |
Mystical experiences occasioned by the hallucinogen psilocybin lead to... |
J Psychopharmacol |
2011 |
| Griffiths RR, Johnson MW,... |
Psilocybin occasioned mystical-type experiences: immediate and persist... |
Psychopharmacology (... |
2011 |
| Reissig CJ, Carter LP, Jo... |
High doses of dextromethorphan, an NMDA antagonist, produce effects si... |
Psychopharmacology (... |
2012 |
| Johnson MW, Garcia-Romeu ... |
Pilot study of the 5-HT2AR agonist psilocybin in the treatment of toba... |
J Psychopharmacol |
2014 |
| Johnson MW, MacLean KA, C... |
Time course of pharmacokinetic and hormonal effects of inhaled high-do... |
J Psychopharmacol |
2016 |
| Carbonaro TM, Bradstreet ... |
Survey study of challenging experiences after ingesting psilocybin mus... |
J Psychopharmacol |
2016 |
| Johnson MW, Garcia-Romeu ... |
An online survey of tobacco smoking cessation associated with naturali... |
J Psychopharmacol |
2017 |
| Barrett FS, Johnson MW, G... |
Neuroticism is associated with challenging experiences with psilocybin... |
Personality and Indi... |
2017 |
| Carbonaro TM, Johnson MW,... |
Double-blind comparison of the two hallucinogens psilocybin and dextro... |
Psychopharmacology (... |
2017 |
| Mounteney J, Griffiths P,... |
Nine reasons why ecstasy is not quite what it used to be |
Int J Drug Policy |
2017 |
| Davis AK, Clifton JM, Wea... |
Survey of entity encounter experiences occasioned by inhaled N,N-dimet... |
J Psychopharmacol |
2020 |
| Nicholas B.GiancolaBAClay... |
A “trip” to the ICU: intravenous injection of psilocybin |
Journal of the Acade... |
2021 |
| Nayak SM, Gukasyan N, Bar... |
Classic Psychedelic Coadministration with Lithium, but Not Lamotrigine... |
Pharmacopsychiatry |
2021 |
